电邮这篇文章 Validation of a Quantitative Determination Method for Ormustine in a Lyophilized Dosage Form
- 作者: Bunyatyan N.D.1,2, Nikolaeva L.L.1,3, Olefir Y.V.2, Sanarova E.V.3, Oborotova N.A.1,2, Prokof’ev A.B.1,2, Ignat’eva E.V.3, Yartseva I.V.3, Gulyakin I.D.3
-
隶属关系:
- I. M. Sechenov First Moscow State Medical University (Sechenov University)
- Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
- N. N. Blokhin Russian Oncological Research Center, Russian Academy of Medical Sciences
- 期: 卷 51, 编号 11 (2018)
- 页面: 1037-1040
- 栏目: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/244899
- DOI: https://doi.org/10.1007/s11094-018-1735-3
- ID: 244899
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
订阅存取
详细
Validation results for a spectrophotometric quantitative determination method for ormustine in a lyophilized dosage form are presented. The method is shown to be suitable for quantitative determination of ormustine with respect to parameters such as specificity, linearity, accuracy, repeatability, and intermediate precision.
作者简介
N. Bunyatyan
I. M. Sechenov First Moscow State Medical University (Sechenov University); Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
编辑信件的主要联系方式.
Email: ndbun@mail.ru
俄罗斯联邦, Moscow, 119991; Moscow, 127051
L. Nikolaeva
I. M. Sechenov First Moscow State Medical University (Sechenov University); N. N. Blokhin Russian Oncological Research Center, Russian Academy of Medical Sciences
Email: ndbun@mail.ru
俄罗斯联邦, Moscow, 119991; Moscow, 115478
Yu. Olefir
Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
Email: ndbun@mail.ru
俄罗斯联邦, Moscow, 127051
E. Sanarova
N. N. Blokhin Russian Oncological Research Center, Russian Academy of Medical Sciences
Email: ndbun@mail.ru
俄罗斯联邦, Moscow, 115478
N. Oborotova
I. M. Sechenov First Moscow State Medical University (Sechenov University); Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
Email: ndbun@mail.ru
俄罗斯联邦, Moscow, 119991; Moscow, 127051
A. Prokof’ev
I. M. Sechenov First Moscow State Medical University (Sechenov University); Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
Email: ndbun@mail.ru
俄罗斯联邦, Moscow, 119991; Moscow, 127051
E. Ignat’eva
N. N. Blokhin Russian Oncological Research Center, Russian Academy of Medical Sciences
Email: ndbun@mail.ru
俄罗斯联邦, Moscow, 115478
I. Yartseva
N. N. Blokhin Russian Oncological Research Center, Russian Academy of Medical Sciences
Email: ndbun@mail.ru
俄罗斯联邦, Moscow, 115478
I. Gulyakin
N. N. Blokhin Russian Oncological Research Center, Russian Academy of Medical Sciences
Email: ndbun@mail.ru
俄罗斯联邦, Moscow, 115478
补充文件
